Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Feasibility of Different Doses of Etomidate Admixed With Propofol in Induced Abortion: A Randomized, Double Blind Controlled Trial

NCT02208596 is registered in ClinicalTrials.gov with Third Affiliated Hospital of Zhengzhou University as lead sponsor.

NCT NCT02208596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02208596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Feasibility of Different Doses of Etomidate Admixed With Propofol in Induced Abortion: A Randomized, Double Blind Controlled Trial
Lead sponsor
Third Affiliated Hospital of Zhengzhou University
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2014
Completion date
February 28, 2015
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, induced abortion